{"id":62165,"date":"2025-11-08T07:04:16","date_gmt":"2025-11-08T06:04:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/"},"modified":"2025-11-08T07:04:16","modified_gmt":"2025-11-08T06:04:16","slug":"omron-releases-the-medium-term-roadmap-sf-2nd-stage","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/","title":{"rendered":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d"},"content":{"rendered":"
\n

KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its \u201cMedium-Term Roadmap Shaping the Future 2nd Stage (\u201cSF 2nd Stage\u201d),\u201d covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group\u2019s vision and growth strategies through 2030, which are disclosed on our corporate website.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nOverview of the \u201cMedium-Term Roadmap SF 2nd Stage\u201d<\/span><\/b>\n<\/p>\n

\nSince April 2024, OMRON has been implementing a Structural Reform Program \u201cNEXT 2025\u201d aimed at rebuilding our foundation for profitability and growth. With the completion of this Program in September 2025, we have shifted into a growth phase and formulated a new Roadmap looking ahead to 2030.\n<\/p>\n

\nThis Roadmap identifies Business Portfolio Restructuring as a core strategy. We have defined Thirteen Focus Businesses to drive the Group\u2019s future growth. By accelerating our selection and concentration efforts, we aim to build a \u201cdistinctive\u201d business portfolio that maximizes overall Group growth. Furthermore, to maximize the growth potential of our Focus Businesses, we will drive transformation decisively across three areas, \u201cVALUE\u201d, \u201cFRONT\u201d, and \u201cResource Allocation.\u201d\n<\/p>\n

\nBuilding on the profit foundation established through Structural Reform Program, we will thoroughly enhance our business growth capabilities and aim to increase corporate value through sustainable, profit-driven growth.\n<\/p>\n

\nRelated Information<\/span><\/b>\n<\/p>\n

\nMedium-Term Roadmap SF 2nd Stage<\/a>\n<\/p>\n

\nAbout OMRON<\/span><\/b>\n<\/p>\n

\nOMRON Corporation, as a leading automation company centered on its unique \u201cSensing & Control + Think\u201d technology, develops businesses in Factory Automation, Healthcare, Social systems, Device and module, and Data solutions that utilize a wide variety of data acquired through these businesses. Founded in 1933, OMRON now employs about 27,000 people worldwide, provides products and services in more than 130 countries, and contributes to the creation of a better society.
\n
Please visit the OMRON website<\/a> for additional information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Department
\n
OMRON Corporation
\n
E-Mail: omron-ir@omron.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its \u201cMedium-Term Roadmap Shaping the Future 2nd Stage (\u201cSF 2nd Stage\u201d),\u201d covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group\u2019s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the \u201cMedium-Term Roadmap SF 2nd Stage\u201d Since … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62165","6":"format-standard","7":"category-industry"},"yoast_head":"\nOMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its \u201cMedium-Term Roadmap Shaping the Future 2nd Stage (\u201cSF 2nd Stage\u201d),\u201d covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group\u2019s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the \u201cMedium-Term Roadmap SF 2nd Stage\u201d Since ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-08T06:04:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d\",\"datePublished\":\"2025-11-08T06:04:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/\"},\"wordCount\":291,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106248559\\\/en\\\/2633195\\\/22\\\/blue_logo_whitebg_rectangle.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/\",\"name\":\"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106248559\\\/en\\\/2633195\\\/22\\\/blue_logo_whitebg_rectangle.jpg\",\"datePublished\":\"2025-11-08T06:04:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106248559\\\/en\\\/2633195\\\/22\\\/blue_logo_whitebg_rectangle.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106248559\\\/en\\\/2633195\\\/22\\\/blue_logo_whitebg_rectangle.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/","og_locale":"en_US","og_type":"article","og_title":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend","og_description":"KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its \u201cMedium-Term Roadmap Shaping the Future 2nd Stage (\u201cSF 2nd Stage\u201d),\u201d covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group\u2019s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the \u201cMedium-Term Roadmap SF 2nd Stage\u201d Since ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-08T06:04:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d","datePublished":"2025-11-08T06:04:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/"},"wordCount":291,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/","url":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/","name":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg","datePublished":"2025-11-08T06:04:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251106248559\/en\/2633195\/22\/blue_logo_whitebg_rectangle.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/omron-releases-the-medium-term-roadmap-sf-2nd-stage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"OMRON Releases the \u201cMedium-Term Roadmap SF 2nd Stage\u201d"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62165"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62165\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}